57
report
IMI Socio-economic Impact Assessment Expert Group
This Innovative Medicines Initiative (IMI) report demonstrates how the first projects launched by I
MI made concrete improvements to pharmaceutical research and development (R&D); leveraging funding; creating new knowledge and tools; and making Europ
+ Read More
report
Fostering Collaborative Research For Rare Genetic Disease: The Example of Niemann-Pick Type C Disease
Rare disease represents one of the most significant issues facing the medical community and health
care providers worldwide, yet the majority of these disorders never emerge from their obscurity, drawing little attention from the medical community or th
+ Read More
report
IBD Plexus: Partnering to Accelerate Science
IBD Plexus is a research and information exchange platform whose goal is to accelerate research and
transform the care of patients with inflammatory bowel disease (IBD).
+ Read More
report
Neurofibromatosis Preclinical Initiatives (NFPI)
The NF Preclinical Initiative (NFPI) represents one of the Children’s Tumor Foundation’s groundbrea
king models of scientific collaboration.
+ Read More
report
University-Foundation Relations: From Transactional to Transformative Partnerships
In biomedical research, both nonprofit disease foundations and academic research institutions are c
ommitted to translating research into effective therapies for patients.
+ Read More
report
Venture Philanthropy Legal Report: The Importance of An Interruption License
This report is one in a series on legal issues of interest to non-profit organizations engaged in o
r thinking about Venture Philanthropy work. It discusses the beginnings of Venture Philanthropy in drug development, the importance of an Interruptio
+ Read More
report
Framing the Issues: Building Securitization Markets in Africa to Advance the SDGs
Despite their promise, securitization markets are under-developed in many developing and emerging m
arket countries, including across the continent of Africa, where the SDG financing gap is the widest.
+ Read More
report
Innovative Financing for Global Health R&D
Because the eradication of diseases like tuberculosis and malaria would have a dramatic impact on e
merging economies, investors in these countries including multinational aid providers, foundations, corporations and institutional funds sought to work to
+ Read More
report
Innovative Financing Models for Energy Infrastructure in Africa
As of 2014, the infrastructure needs of Sub-Saharan Africa were expected to exceed US$93B annually
over 10 years.
+ Read More
report
Common Capital Market Infrastructure for East Africa: Options for the Way Forward
Growth in capital markets in the East African Community (EAC) has not kept up with the pace of econ
omic growth.
+ Read More
report
Innovative Finance to Address Africa’s Infrastructure Needs
As of 2015, African state governments had financed infrastructure development on their balance shee
ts alone, resulting in slower progress constrained by budgetary restrictions. In many regions across the African continent, the poor state of infrast
+ Read More
report
Catalytic Finance for Nutrition
This report presents conclusions from a two-day Financial Innovations Lab® on catalytic financing f
or nutrition facilitated by the Milken Institute in May 2013.
+ Read More